Peggy J. Berry, MBA, RAC, is the President & CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics. Prior to founding Synergy Consulting in 2015, she was Vice President of Regulatory Affairs at Insmed where she was responsible for the development and implementation of global regulatory strategies and the management and oversight of the regulatory affairs department. Prior to Insmed, she was Vice President of Regulatory Affairs and Quality at Amarin. In addition, Ms. Berry consults for a number of companies in the regulatory and quality area, conducts a number of training courses, and is active in the Regulatory Affairs Professionals Society. She is the editor of the 2010 book “Choosing the Right Regulatory Career” (RAPS, MD) and author of the 2011 book “Communication & Negotiation” (RAPS, MD).

Regulatory Affairs

Prof David Naor is a professor of immunology in the Hebrew University, faculty of Medicine and was the head of Milton Winograd Chair of Cancer Studies. He received his Ph.D from the Hebrew University. He served as visiting professor in leading universities (e.g., UCLA, Harvard). He published 152 articles, including in leading journals like Nature, PNAS, J Clin Invest, J immunol, J Exp Med etc. He was invited to speak on CD44 at 8 plenary sessions of international conferences. He has been a member in editorial boards of several international scientific journals and he is an associate editor of Frontiers in Immunology. He is on the scientific board of International Congress on Autoimmunity. He received awards from Johnson & Johnson "In recognition of outstanding research towards the advances of science and technology in health care” and from the Hebrew University for his “outstanding achievements in research and teaching”.

Prof David Naor current research has been focused on the role of CD44 and other hyaluronan-binding molecules (e.g., RHAMM) in autoimmune and cancer diseases. This CD44 research yielded 34 articles, which were cited thousands of times.

Christina Leung completed two Bachelor degrees in England (the Management Sciences degree and the Pharmacy degree). Following the registration as a pharmacist in England, she worked in a number of teaching hospitals in London. After the completion of junior pharmacist training, Ms Leung spent 12 years as Women’s and Children’s Pharmacist, mainly specialising in Paediatric ICU, Paediatric Liver, Obstetrics & Gynaecology. She published a number of articles including two articles relating to drugs use in paediatric liver diseases. Ms Leung is also a registered pharmacist in HK and she is currently working as the Senior Pharmacist (Clincial Service) at HKU-SZH. She is currently the Honorary Lecturer at the University of Hong Kong.

Ms Leung has special intertess in clincial pharmacy system of different aspects and its impact in the quality of patient care. In addition, Ms Leung has great interests in medication safety, risk management, antimicrobial stewardship, quality management, training and education, and continuous professional development.

Gopal Natesan has completed his Doctoral degree (PhD) in Pharmaceutical Chemistry from Hamdard University (Jamia Hamdard) New Delhi, India in 2000 and currently serving as Professor of Medicinal Chemistry & Deputy Dean of Research & Innovation in Faculty of Pharmacy, MAHSA University, Kuala Lumpur, Malaysia. His research focuses on the synthesis of newer small chemical entities, quinazolinones heterocyclic pharmacophore and their preliminary screening in both in-vivo and in- vitro models mainly focusing on pain & inflammation and also for newer microbial agents. He has published >40 articles in indexed journals and presented >80 papers in conferences and received number of honors, recently received “Young Scientist Award” in 2013 and “Edward Kennedy Memorial Award” for his high standards of research excellence in Science and Technology. He was invited speaker at international scientific meetings and conferences and serves as reviewer for several scientific international journals and also as Editorial/Advisory board of various journals.

Pharmaceutical Chemistry

After completion of his postdoctoral training at University of Texas MD Anderson Cancer Center, Prof. Gautam Sethi joined Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore in 2008 as an Assistant Professor and was promoted to Associate Professor in 2015. The focus of his research over the past few years has been to elucidate the mechanism(s) of activation of oncogenic transcription factors such as NF KB/STAT3 by carcinogens and inflammatory agents and the identification of novel inhibitors of these proteins for prevention of and therapy for cancer. From traditional Chinese and Indian medicinal plants, his group has identified numerous small molecules that can suppress various pro-tumorigenic signaling cascades involved in cancer initiation and promotion. The novel findings of his research work have so far resulted in more than one fifty scientific publications in high impact factor peer reviewed journals and several international awards. He currently serves as an Academic Editor for prestigious PLOS One journal and ad-hoc reviewer for several other international journals.

Pharmacology

Dr Yahaya Hassan is a Professor of Clinical Pharmacy, Pharmacy Practice Department at Faculty of Pharmacy,Universiti Teknologi MARA (UiTM), Malaysia. He also serve as a consultant for Malaysian Qualifying Agency (MQA) Ministry of Higher Education of Malaysia and MQA panel member for Board of Pharmacy of Malaysia. He also serve as a committee member of Clinical Pharmacy Specialist development program for Pharmacy Division,Ministry of Health of Malaysia. Prof Yahaya obtained his B.Pharm from Universiti Sains Malaysia and Pharm.D. from University of Minnesota, USA. He has been lecturing at the faculty of Pharmacy for 32 years covering courses in clinical pharmacy, pharmacokinetics, advanced pharmacotherapeutics and pharmacy practice. He has successfully supervised over 20 research postgraduate students at the master’s and Ph.D levels, more than 200 master’s by coursework and published over 110 research papers in international journals and another 40 in regional and local journals.

His current research interest focus on clinical pharmacy, pharmacoepidemiology and pharmaceutical outcome study.

Dr Aref Alabed, A competent manager with extensive years of experience in leading arnmedical facility. He implements policies and procedures, focusing on the development ofrnthe organization by fulfilling the mission, vision and goals. The objectives are his top priorities. Dr. Aref is a Dentist , holding an MBA with Merit from Northampton university in UK, he is the Founder & CEO for the International Medical Training Academy in London, and an international relations Consultant for the Largest Chain of pharmacies in Jordan with more than 100 pharmacies today (Dawacom). He was the Marketing director and built the Marketing department from scratch.

Healthcare, Medical services, Training.